EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Community pharmacists' practices and perspectives on deprescribing high‐risk psychotropic medicines: National survey findings

Monica Jung iD, Louisa Picco, Aili V Langford, Rose Laing, Jana Dostal, Suzanne Nielsen iD

British Journal of Clinical Pharmacology · 2026

DOI: 10.1002/bcp.70466 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, 2026. Verfasst von Monica Jung und 5 weiteren Autor:innen. Beteiligte Einrichtung: Monash Addiction Research Centre, Eastern Health Clinical School, Monash University, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Psychotropic Drugs, Pharmacists, Community Pharmacy Services, Deprescriptions. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council Investigator, National Health and Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To explore the practices, confidence and perspectives of community pharmacists in deprescribing high‐risk psychotropic medicines, including opioid analgesics, benzodiazepine, gabapentinoids and medicinal cannabis.

Methods

An anonymous, cross‐sectional national online survey was conducted between January and April 2025 among Australian community pharmacists. The survey captured data on pharmacist demographics, their workplace (pharmacy) characteristics, their provision of high‐risk psychotropic medicines, and pharmacists' perspectives, confidence and practices related to implementing strategies to support deprescribing of these medicines. Descriptive statistics and logistic regression analyses were conducted to explore the factors associated with initiating discussions with patients about deprescribing.

Results

The sample comprised of 730 pharmacists, representing approximately 12% of all Australian community pharmacies. Approximately three‐quarters indicated their pharmacy received prescriptions every day for opioids (80.6%), benzodiazepines (75.2%) and gabapentinoids (72.1%), whilst fewer than one‐tenth of pharmacies (8.9%) received medicinal cannabis prescriptions every day. Pharmacists working outside of capital cities (i.e. other urban, rural or remote areas; adjusted odds ratio (aOR): 1.33, 95% confidence intervals (CIs): 0.97–1.83), pharmacy managers/owners (aOR: 1.29, 95% CIs: 1.22–1.50) and those with ≥ 15 years of professional experience (OR: 1.57, 95% CIs: 1.17–2.11) had higher odds of initiating discussions on deprescribing psychotropic medicines compared with those working in capital cities, employee pharmacists and those with

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Psychotropic DrugsPharmacistsCommunity Pharmacy ServicesDeprescriptionsPractice Patterns, Pharmacists'HumansCross-Sectional StudiesFemaleAustraliaMaleAdultMiddle AgedSurveys and QuestionnairesAttitude of Health Personnel

Stichwörter der Autor:innen

benzodiazepinescommunity pharmacy practicedeprescribinggabapentinoidsmedicinal cannabisopioids

Substanzen

Psychotropic Drugs

Autor:innen und Institutionen

  • Monash Addiction Research Centre, Eastern Health Clinical School, Monash University, Melbourne, Victoria, Australia.
  • Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
  • Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.

ORCID-Profile: Monica Jung, Suzanne Nielsen

Förderung

  • National Health and Medical Research Council Investigator
  • National Health and Medical Research Council

Zitieren

APA

Jung, M., Picco, L., Langford, A. V., Laing, R., Dostal, J., & Nielsen, S. (2026). Community pharmacists' practices and perspectives on deprescribing high‐risk psychotropic medicines: National survey findings. British Journal of Clinical Pharmacology. https://doi.org/10.1002/bcp.70466

Vancouver

Jung M, Picco L, Langford AV, Laing R, Dostal J, Nielsen S. Community pharmacists' practices and perspectives on deprescribing high‐risk psychotropic medicines: National survey findings. British Journal of Clinical Pharmacology. 2026. doi:10.1002/bcp.70466

BibTeX
@article{Jung2026,
  author = {Jung, Monica and Picco, Louisa and Langford, Aili V and Laing, Rose and Dostal, Jana and Nielsen, Suzanne},
  title = {Community pharmacists' practices and perspectives on deprescribing high‐risk psychotropic medicines: National survey findings},
  journal = {British Journal of Clinical Pharmacology},
  year = {2026},
  doi = {10.1002/bcp.70466}
}
Kostenlos starten →